Table I Index
Table of Contents

Table I - 26
Gibson
Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana

Primary Site

Total

Males Females
Number Rate Number Rate Number Rate
All sites 155 369.9 77 421.5 78 334.2
Oral cavity and pharynx * # * # * #
Lip * # * # * #
Tongue * # * # * #
Major salivary glands * # * # * #
Floor of mouth * # * # * #
Gum and other mouth * # * # * #
Nasopharynx * # * # * #
Tonsil * # * # * #
Oropharynx * # * # * #
Hypopharynx * # * # * #
Pharynx and other oral cavity * # * # * #
Digestive system 28 66.7 19 107.1** 9 35.0**
Esophagus * # * # * #
Stomach * # * # * #
Small intestine * # * # * #
Colon excluding rectum 12 27.3** 8 43.4** * #
Rectum and rectosigmoid 5 11.7** 5 27.2** * #
Anus, anal canal, and anorectum * # * # * #
Liver and intrahepatic bile duct * # * # * #
Gallbladder * # * # * #
Other biliary * # * # * #
Pancreas * # * # * #
Retroperitoneum * # * # * #
Peritoneum * # * # * #
Other digestive organs * # * # * #
Respiratory system 28 63.8 16 84.6** 12 48.7**
Nasal cavity, ear, and sinuses * # * # * #
Larynx * # * # * #
Lung and bronchus 27 60.8 16 84.6** 11 43.1**
Trachea, pleura, and other respiratory organs * # * # * #
Bones and joints * # * # * #
Soft tissue (including heart) * # * # * #
Skin (excluding basal and squamous) 6 15.7** * # * #
Melanoma of the skin 6 15.7** * # * #
Other non-epithelial skin cancers * # * # * #
Breast 21 53.8 * # 21 99.6
Female genital system 15 35.4** -- -- 15 65.2**
Cervix uteri * # -- -- * #
Corpus uteri 9 21.4** -- -- 9 39.0**
Uterus, NOS * # -- -- * #
Ovary * # -- -- * #
Vagina * # -- -- * #
Vulva * # -- -- * #
Other female genital organs * # -- -- * #
Male genital system 21 51.3 21 116.0 -- --
Prostate gland 20 48.1 20 109.6 -- --
Testis * # * # -- --
Penis * # * # -- --
Other male genital organs * # * # -- --
Urinary system 12 26.8** 6 30.2** 6 24.5**
Urinary bladder 5 8.8** * # * #
Kidney and renal pelvis 6 14.9** * # * #
Ureter * # * # * #
Other urinary organs * # * # * #
Eye and orbit * # * # * #
Brain and other nervous system * # * # * #
Brain * # * # * #
Other nervous system * # * # * #
Endocrine system * # * # * #
Thyroid gland * # * # * #
Other endocrine (including thymus) * # * # * #
Lymphoma 6 12.5** * # * #
Hodgkin’s disease * # * # * #
Non-Hodgkin’s lymphoma 6 12.5** * # * #
Multiple myeloma * # * # * #
Leukemia * # * # * #
Acute lymphocytic * # * # * #
Chronic lymphocytic * # * # * #
Acute myeloid * # * # * #
Chronic myeloid * # * # * #
Other leukemias * # * # * #
Other, ill-defined and unknown sites 5 11.2** * # * #

1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than twenty cases are unstable.
# Rate cannot be calculated.
_______________________________________________________________

Source:  Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001

Table I Index
Table of Contents